These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37179967)

  • 1. Evaluation of the Cytonucleomorphometric Parameters for Cases Diagnosed as Squamous Cell Abnormality on Conventional Cervico-Vaginal Pap Smears.
    Mishra S; Khurana U; Kapoor N; Joshi A; Joshi D
    J Cytol; 2023; 40(1):5-11. PubMed ID: 37179967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute.
    Yang J; Nolte FS; Chajewski OS; Lindsey KG; Houser PM; Pellicier J; Wang Q; Ehsani L
    Diagn Cytopathol; 2018 Jan; 46(1):22-27. PubMed ID: 29048733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion" as a distinct squamous abnormality category in Papanicolaou tests.
    Elsheikh TM; Kirkpatrick JL; Wu HH
    Cancer; 2006 Oct; 108(5):277-81. PubMed ID: 16937376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of atypical squamous cells on conventional cytology smears: An experience from a screening program practiced in limited resource settings.
    Rekhi B; Ajit D; Joseph SK; Gawas S; Deodhar KK
    Cytojournal; 2010 Aug; 7():15. PubMed ID: 20806086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
    Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K
    Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Squamous intraepithelial lesions (SIL: LSIL, HSIL, ASCUS, ASC-H, LSIL-H) of Uterine Cervix and Bethesda System.
    Alrajjal A; Pansare V; Choudhury MSR; Khan MYA; Shidham VB
    Cytojournal; 2021; 18():16. PubMed ID: 34345247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of the ThinPrep Imaging System in a tertiary military medical center.
    Duby JM; DiFurio MJ
    Cancer; 2009 Aug; 117(4):264-70. PubMed ID: 19536887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality metrics in cervical cytopathology: A single institutional study.
    Senthil Kumar D; Ravikumar G
    Cytopathology; 2022 Mar; 33(2):230-235. PubMed ID: 34854153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of micronucleus scoring in cervical papanicolaou smears: A 1-year study.
    Tiwana KK; Kaur M; Goyal S; Bhandhari L
    Ann Afr Med; 2022; 21(4):355-360. PubMed ID: 36412334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities.
    Zhao C; Zhao S; Heider A; Austin RM
    Arch Pathol Lab Med; 2010 Aug; 134(8):1130-5. PubMed ID: 20670132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of micronucleus in cervical intraepithelial lesions and carcinoma.
    Gayathri B; Kalyani R; Hemalatha A; Vasavi B
    J Cytol; 2012 Oct; 29(4):236-40. PubMed ID: 23326026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical importance of "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion (LSIL-H)" terminology for cervical smears 5-year analysis of the positive predictive value of LSIL-H compared with ASC-H, LSIL, and HSIL in the detection of high-grade cervical lesions with a review of the literature.
    Ince U; Aydin O; Peker O
    Gynecol Oncol; 2011 Apr; 121(1):152-6. PubMed ID: 21211831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposed Sheffield quantitative criteria in cervical cytology to assist the diagnosis and grading of squamous intra-epithelial lesions, as some Bethesda system definitions require amendment.
    Slater DN; Rice S; Stewart R; Melling SE; Hewer EM; Smith JH
    Cytopathology; 2005 Aug; 16(4):168-78. PubMed ID: 16048503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the low-grade squamous intraepithelial lesion/atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion category associated with cervical intraepithelial neoplasia 2?
    Cetiner H; Kır G; Kaygusuz E; Sağlıcan Y; Kabaca C
    Acta Cytol; 2013; 57(6):581-4. PubMed ID: 24107612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of high-risk human papillomavirus testing in women with abnormal cytology].
    Ou H; Bian ML; Zhang XY; Chen QY; Li M; Chen Y; Liu J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):608-11. PubMed ID: 18051714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with epithelial cell abnormality in PAP smears: correlation of results with follow-up smears and cervical biopsies.
    Türkmen IÇ; Başsüllü N; Korkmaz P; Günenç B; Baykal CM; Güdücü N; Işçı H; Dünder I; Doğusoy GB
    Turk Patoloji Derg; 2013; 29(3):179-84. PubMed ID: 24022307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Cervical Cancer Biomarkers p16 and Ki67 in Abnormal Cervical Cytological Smear.
    Gothwal M; Nalwa A; Singh P; Yadav G; Bhati M; Samriya N
    J Obstet Gynaecol India; 2021 Feb; 71(1):72-77. PubMed ID: 33814802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-grade squamous intraepithelial lesion, cannot rule out high-grade lesion: Diagnosis, histological outcomes and human papillomavirus results.
    Segura SE; Ramos-Rivera G; Hakima L; Suhrland M; Khader S
    Cytopathology; 2019 Jan; 30(1):99-104. PubMed ID: 30187975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cytological screening and management in pregnant and postpartum women.
    He GF; Bian ML; Wang Y; Liu XY
    Chin Med Sci J; 2005 Dec; 20(4):242-6. PubMed ID: 16422252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Performance of CinTec® PLUS in SurePathTM Liquid-Based Cervico-Vaginal Samples.
    Sharma P; Gupta P; Gupta N; Suri V; Rajwanshi A
    Turk Patoloji Derg; 2021; 37(1):32-38. PubMed ID: 33372263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.